Has obtained patent in the United States until 2033 for the combination of tesofensine and Metoprolol

Saniona, a leading biotech company in the field of ion channels, today announces that the United States Patent and Trademark Office has issued a patent covering the combination of tesofensine and Metoprolol. The patent for Tesomet expires in the U.S. in 2033.

The release as fetched from its publisher. saniona.com ↗